Clinical Trials on High Risk Localized Prostate Cancer in China
Total 412 results
-
Qilu Hospital of Shandong UniversityRecruiting
-
Tongji HospitalXiangya Hospital of Central South University; Chinese PLA General Hospital; Hubei...Recruiting
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Active, not recruiting
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Unknown
-
Subei People's Hospital of Jiangsu ProvinceUnknown
-
West China HospitalUnknown
-
Jiangsu HengRui Medicine Co., Ltd.Enrolling by invitationHormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast CancerChina
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Shanghai Proton and Heavy Ion CenterRecruitingProstate Cancer | RadiotherapyChina
-
Changhai HospitalRecruiting
-
Shanghai East HospitalNot yet recruitingProstate Cancer | TreatmentChina
-
Affiliated Hospital of Jiangnan UniversityRecruiting
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Prostatype Genomics AB; GloriousMed Clinical Laboratory (Shanghai) Co., Ltd.RecruitingProstate CancerChina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Not yet recruitingProstate CancerChina
-
The First Affiliated Hospital of Guangdong Pharmaceutical...University of Technology, Sydney; Guangzhou Anjie Biomedical Technology Co....Unknown
-
Zhengzhou UniversityThe First Affiliated Hospital of Zhengzhou University; Luoyang Central Hospital and other collaboratorsCompleted
-
Accutar Biotechnology IncTerminatedMetastatic Castration Resistant Prostate CancerChina
-
Ruijin HospitalRecruitingProstate Cancer | PSMA | p2PSAChina
-
Pengyuan LiuRecruitingMetastatic Castration-resistant Prostate Cancer (CRPC)China
-
Fudan UniversityCompleted
-
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou Medical UniversityRecruiting
-
Jiangnan UniversityAffiliated Hospital of Jiangnan UniversityCompletedCastration-resistant Prostate CancerChina
-
Hongqian GuoFirst Affiliated Hospital of Zhejiang University; Nanjing First Hospital, Nanjing... and other collaboratorsRecruitingNeoadjuvant TherapyChina
-
The First Affiliated Hospital with Nanjing Medical...The First Affiliated Hospital of Soochow UniversityRecruitingthe Application of Artificial Intelligence in the Diagnosis of Prostate CancerChina
-
Hansoh BioMedical R&D CompanyRecruitingMetastasis Castration Resistant Prostate Cancer(mCRPC)China
-
Shanghai East HospitalChinese University of Hong Kong; Chongqing Medical University; The First Affiliated... and other collaboratorsCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingModerate and High Risk MyelofibrosisChina
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaActive, not recruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerJapan
-
Wuhan Union Hospital, ChinaRecruitingProstate Cancer | PET/MR | PET/CTChina
-
TakedaCompletedHormone Treatment-naïve Participants With Prostate CancerJapan
-
Sun Yat-sen UniversityRecruiting
-
Second Affiliated Hospital, School of Medicine,...Completed
-
InSightecTerminatedProstate CancerChina, Canada, United Kingdom
-
First Affiliated Hospital of Chongqing Medical...RecruitingPregnancy, High Risk | Pulmonary HypertensionChina
-
Shanghai Mental Health CenterCompletedClinical High Risk for PsychosisChina
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingMetastatic Castration-resistant Prostate CancerChina
-
Peking University First HospitalCompletedPostoperative Nausea and Vomiting | High-risk Patients | BenzodiazepineChina
-
Xiaojun ChenChongqing University Cancer Hospital; Sun Yat-sen University; Fudan University; Tongji Hospital and other collaboratorsRecruitingPrognosis | Middle-high Risk Endometrial Cancer | Sentinel Lymph Node SamplingChina
-
Sun Yat-sen UniversityJiangsu Hansoh Pharmaceutical Co., Ltd.UnknownSolid Tumor Patients Receiving High Emetic Risk Multi-day ChemotherapyChina
-
Capital Medical UniversityUnknown
-
Telix Pharmaceuticals (Innovations) Pty LimitedGrand Pharmaceutical (China) Co., Ltd.RecruitingProstate Cancer | Biochemical Recurrence of Malignant Neoplasm of Prostate | BCR Prostate CarcinomaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
Shanghai East HospitalNot yet recruiting
-
Peking University First HospitalRecruiting
-
Peking University Third HospitalBayerNot yet recruiting
-
Peking University First HospitalRecruiting
-
HTA Co., Ltd.Recruiting
-
Shanghai Unicar-Therapy Bio-medicine Technology...The First Affiliated Hospital of Soochow UniversityRecruiting